Vicki L. Ellingrod
Vicki L. Ellingrod
John Gideon Searle Professor of Clincal and Translational Pharmacy
Dirección de correo verificada de
Citado por
Citado por
Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC®) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update
JK Hicks, K Sangkuhl, JJ Swen, VL Ellingrod, DJ Müller, K Shimoda, ...
Clinical pharmacology and therapeutics 102 (1), 37, 2017
Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants
JK Hicks, JJ Swen, CF Thorn, K Sangkuhl, ED Kharasch, VL Ellingrod, ...
Clinical Pharmacology & Therapeutics 93 (5), 402-408, 2013
Pooled analysis of antidepressant levels in lactating mothers, breast milk, and nursing infants
AM Weissman, BT Levy, AJ Hartz, S Bentler, M Donohue, VL Ellingrod, ...
American Journal of Psychiatry 161 (6), 1066-1078, 2004
Antipsychotic‐induced hyperprolactinemia
JR Bostwick, SK Guthrie, VL Ellingrod
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 29 (1 …, 2009
Interaction between atypical antipsychotics and the gut microbiome in a bipolar disease cohort
SA Flowers, SJ Evans, KM Ward, MG McInnis, VL Ellingrod
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 37 (3 …, 2017
Weight gain associated with the− 759C/T polymorphism of the 5HT2C receptor and olanzapine
VL Ellingrod, PJ Perry, JC Ringold, BC Lund, K Bever‐Stille, F Fleming, ...
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 134 …, 2005
Psychosexual effects of three doses of testosterone cycling in normal men
WR Yates, PJ Perry, J MacIndoe, T Holman, V Ellingrod
Biological psychiatry 45 (3), 254-260, 1999
Clozapine‐induced weight gain associated with the 5HT2C receptor− 759C/T polymorphism
DD Miller, VL Ellingrod, TL Holman, PF Buckley, S Arndt
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 133 …, 2005
Venlafaxine: a heterocyclic antidepressant
VL Ellingrod, PJ Perry
American Journal of Health-System Pharmacy 51 (24), 3033-3046, 1994
Effects of cigarette smoking on metabolism and effectiveness of systemic therapy for lung cancer
M O’Malley, AN King, M Conte, VL Ellingrod, N Ramnath
Journal of thoracic oncology 9 (7), 917-926, 2014
Metabolic syndrome in bipolar disorder and schizophrenia: dietary and lifestyle factors compared to the general population
MJ Bly, SF Taylor, G Dalack, R Pop‐Busui, KJ Burghardt, SJ Evans, ...
Bipolar disorders 16 (3), 277-288, 2014
Metabolic syndrome and insulin resistance in schizophrenia patients receiving antipsychotics genotyped for the methylenetetrahydrofolate reductase (MTHFR) 677C/T and 1298A/C …
VL Ellingrod, DD Miller, SF Taylor, J Moline, T Holman, J Kerr
Schizophrenia research 98 (1-3), 47-54, 2008
Serotonin 2A− 1438 G/A and G-protein Beta3 subunit C825T polymorphisms in patients with depression and SSRI-associated sexual side-effects
JR Bishop, J Moline, VL Ellingrod, SK Schultz, AH Clayton
Neuropsychopharmacology 31 (10), 2281-2288, 2006
Variants of the dopamine D2 receptor gene and risperidone-induced hyperprolactinemia in children and adolescents
CA Calarge, VL Ellingrod, L Acion, DD Miller, J Moline, MJ Tansey, ...
Pharmacogenetics and genomics 19 (5), 373-382, 2009
Systematic review and meta-analysis of pharmacological interventions for weight gain from antipsychotics and mood stabilizers
J G Fiedorowicz, D Del Miller, J R Bishop, C A Calarge, V L Ellingrod, ...
Current psychiatry reviews 8 (1), 25-36, 2012
C3435T mutation in exon 26 of the human MDR1 gene and cyclosporine pharmacokinetics in healthy subjects
DI Min, VL Ellingrod
Therapeutic drug monitoring 24 (3), 400-404, 2002
Risk factors associated with metabolic syndrome in bipolar and schizophrenia subjects treated with antipsychotics: the role of folate pharmacogenetics
VL Ellingrod, SF Taylor, G Dalack, TB Grove, MJ Bly, RD Brook, ...
Journal of clinical psychopharmacology 32 (2), 261-265, 2012
Leptin and leptin receptor gene polymorphisms and increases in body mass index (BMI) from olanzapine treatment in persons with schizophrenia.
VL Ellingrod, JR Bishop, J Moline, YC Lin, DD Miller
Psychopharmacology bulletin 40 (1), 57-62, 2007
Association between the polymorphic GRM3 gene and negative symptom improvement during olanzapine treatment
JR Bishop, VL Ellingrod, J Moline, D Miller
Schizophrenia research 77 (2-3), 253-260, 2005
CYP3A5 polymorphism and the ethnic differences in cyclosporine pharmacokinetics in healthy subjects 1
DI Min, VL Ellingrod, S Marsh, H McLeod
Therapeutic drug monitoring 26 (5), 524-528, 2004
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20